Ablynx expands into new R&D facility
23-Jun-2010
- Belgium
"This new cutting-edge laboratory building will support Ablynx's growth in the foreseeable future. This allows us to house our Belgian operations in one facility", said Dr Edwin Moses, Chief Executive Officer and Chairman of Ablynx. "With over 240 staff we believe Ablynx is one of the most advanced independent, next-generation biologics companies."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Pieris confirms in vivo activity of potent VEGF-specific Anticalin
Go to page
VaxGen Concludes Early Stage Meningitis B Vaccine Collaboration with EndoBiologics
Go to page
Phi_value_analysis
Go to page
Gammaproteobacteria
Go to page
DNA
Go to page
Epithelium
Go to page
New guide to the genetic jungle of muscles can help health research
Go to page
VTT identified specific bacteria which precede autoimmune diabetes - New potential avenues for early disease detection and prevention
Go to page